Xilong Scientific Balance Sheet Health
Financial Health criteria checks 4/6
Xilong Scientific has a total shareholder equity of CN¥2.3B and total debt of CN¥1.2B, which brings its debt-to-equity ratio to 52.9%. Its total assets and total liabilities are CN¥4.7B and CN¥2.4B respectively. Xilong Scientific's EBIT is CN¥92.3M making its interest coverage ratio 1.9. It has cash and short-term investments of CN¥474.0M.
Key information
52.9%
Debt to equity ratio
CN¥1.21b
Debt
Interest coverage ratio | 1.9x |
Cash | CN¥474.05m |
Equity | CN¥2.29b |
Total liabilities | CN¥2.39b |
Total assets | CN¥4.68b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002584's short term assets (CN¥3.2B) exceed its short term liabilities (CN¥2.0B).
Long Term Liabilities: 002584's short term assets (CN¥3.2B) exceed its long term liabilities (CN¥357.1M).
Debt to Equity History and Analysis
Debt Level: 002584's net debt to equity ratio (32.2%) is considered satisfactory.
Reducing Debt: 002584's debt to equity ratio has reduced from 68.4% to 52.9% over the past 5 years.
Debt Coverage: 002584's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 002584's interest payments on its debt are not well covered by EBIT (1.9x coverage).